Rassendren F, Buell G N, Virginio C, Collo G, North R A, Surprenant A
Geneva Biomedical Research Institute, GlaxoWellcome Research and Development, Plan-les-Ouates, 1228 Geneva, Switzerland.
J Biol Chem. 1997 Feb 28;272(9):5482-6. doi: 10.1074/jbc.272.9.5482.
A cDNA was isolated from a human monocyte library that encodes the P2X7 receptor; the predicted protein is 80% identical to the rat receptor. Whole cell recordings were made from human embryonic kidney cells transfected with the human cDNA and from human macrophages. Brief applications (1-3 s) of ATP and 2', 3'-(4-benzoyl)-benzoyl-ATP elicited cation-selective currents. When compared with the rat P2X7 receptor, these effects required higher concentrations of agonists, were more potentiated by removal of extracellular magnesium ions, and reversed more rapidly on agonist removal. Longer applications of agonists permeabilized the cells, as evidenced by uptake of the propidium dye YO-PRO1, but this was less marked than for cells expressing the rat P2X7 receptor. Expression of chimeric molecules indicated that some of the differences between the rat and human receptor could be reversed by exchanging the intracellular C-terminal domain of the proteins.
从人单核细胞文库中分离出一种编码P2X7受体的cDNA;预测的蛋白质与大鼠受体有80%的同源性。对转染了人cDNA的人胚肾细胞和人巨噬细胞进行全细胞记录。短暂施加(1 - 3秒)ATP和2',3'-(4-苯甲酰基)-苯甲酰基-ATP可引发阳离子选择性电流。与大鼠P2X7受体相比,这些效应需要更高浓度的激动剂,去除细胞外镁离子时增强作用更明显,去除激动剂后逆转更快。长时间施加激动剂会使细胞透化,如通过碘化丙啶染料YO-PRO1的摄取来证明,但这比表达大鼠P2X7受体的细胞表现得要轻。嵌合分子的表达表明,通过交换蛋白质的细胞内C末端结构域,大鼠和人受体之间的一些差异可以得到逆转。